Lysophosphatidic acid (LPA) is enriched in the serum and malignant effusion of
cancer patients and plays a key role in
tumorigenesis and
metastasis. LPA-activated mesenchymal stem cells promote tumorigenic potentials of
cancer cells through a paracrine mechanism. LPA-
conditioned medium (LPA CM) from human adipose tissue-derived mesenchymal stem cells (hASCs) elicited adhesion and proliferation of A549 human
lung adenocarcinoma cells. To identify
proteins involved in the LPA-stimulated paracrine functions of hASCs, we analyzed the LPA CM using liquid-chromatography tandem mass spectrometry-based shotgun proteomics. We identified βig-h3, an
extracellular matrix protein that is implicated in
tumorigenesis and
metastasis, as an LPA-induced secreted
protein in hASCs. LPA-induced βig-h3 expression was abrogated by pretreating hASCs with the
LPA receptor(1/3) inhibitor
Ki16425 or
small interfering RNA-mediated silencing of endogenous LPA(1). LPA-induced βig-h3 expression was blocked by treating the cells with the
Rho kinase inhibitor
Y27632, implying that LPA-induced βig-h3 expression is mediated by the LPA(1)-
Rho kinase pathway. Immunodepletion or
siRNA-mediated silencing of βig-h3 abrogated LPA CM-stimulated adhesion and proliferation of A549 cells, whereas retroviral overexpression of βig-h3 in hASCs potentiated it. Furthermore, recombinant βig-h3
protein stimulated the proliferation and adhesion of A549 human
lung adenocarcinoma cells. These results suggest that hASC-derived βig-h3 plays a key role in
tumorigenesis by stimulating the adhesion and proliferation of
cancer cells and it can be applicable as a
biomarker and therapeutic target for
lung cancer.